Pharmacy evidence record · researched 2026-08-20

Walgreens

Legal identity not verified in the bound record

5 citations2 action records5 explicit unknowns

Compounded with

Semaglutide

Walgreens Weight Management lists Wegovy with semaglutide as the active ingredient.

Tirzepatide

Walgreens Weight Management lists Zepbound with tirzepatide as the active ingredient.

This evidence concerns FDA-approved branded products and Walgreens weight-management/dispensing services, not compounded semaglutide or tirzepatide. Availability and eligibility vary.

Locations in the source record

A current location was not established by the evidence reviewed.

Services named by sources

  • Retail pharmacy
  • Prescription dispensing
  • Weight-management telehealth
  • Vaccinations and community pharmacy services

Regulatory compliance

503 pathway evidence

A pathway label describes which federal rules apply — it is not a quality claim.

Section 503A

Not conclusively established

No chain-wide 503A compounding classification was verified.

Section 503B

Not conclusively established

No exact Walgreens facility row was verified in FDA's current outsourcing-facility registry; no categorical negative claim is made.

Telehealth providers

No provider relationship is verified in the bound sources.

Clinic Scout links a provider only when an explicit source names the relationship.

Browse provider records

Regulatory history

Actions stay dated and bounded.

Two store-specific Texas agreed orders were verified. FDA exact-chain-name searches did not identify a compounding action specific to the directory target. Nationwide store-level board-action coverage was not attempted.

Texas State Board of Pharmacy · 2025-05-06

Agreed Board Order

A store-specific Texas order concerned a delivery error and failure to provide adequate security for confidential patient records. This is not represented as a chain-wide action.

reprimand_and_1000_penalty

Texas State Board of Pharmacy · 2025-05-06

Agreed Board Order

A store-specific Texas order concerned controlled-substance purchase/disposal records and controls against loss or diversion. This is not represented as a chain-wide action.

reprimand_and_4000_penalty

What remains unverified

No Clinic Scout patient reviews are published for this pharmacy. Submissions go through manual moderation before anything appears here.

What this record verifies for you

4 evidence dimensions carry dated, source-backed verification.

Each line traces to a citation in the source list below — read the exact captured wording before relying on it.

No superiority claim is made for review volume, ratings, or patient sentiment.

Sources and exact captured wording

  1. first_party · accessed 2026-08-20
    8,000 Locations Serving communities across all 50 states and Puerto Rico with trusted pharmacy care and retail services
  2. first_party · accessed 2026-08-20
    Since opening our doors in 1901, we’ve been more than a corner store; we’ve been a cornerstone in the communities we serve.
  3. first_party · accessed 2026-08-20
    Today, Walgreens Weight Management offers GLP-1 agonist medications such as semaglutide (Wegovy® – oral pills & injectable pens), tirzepatide (Zepbound® – injectable KwikPens & vials), orforglipron (Foundayo™ pills), and liraglutide (Saxenda®).
  4. state_board · accessed 2026-08-20
    Walgreens #21464Lic. #34924ABO #2024-04952 | Delivery errorFailure to provide adequatesecurity for confidential patientrecords | 04/30/2024 | Reprimand + $1,000 penalty
  5. state_board · accessed 2026-08-20
    Walgreens #07371Lic. #24436ABO #2024-01540 | Failure to keep and maintaincomplete and accurate records ofpurchases and disposals ofcontrolled substances(3 counts)Failure to maintain controlsagainst loss/diversion ofcontrolled substances | 06/10/2022 –06/09/2023 | Reprimand + $4,000 penalty

Questions readers ask

Is Walgreens legit?

GLP Clinic Scout does not issue a blanket legitimacy verdict. This research record preserves 5 dated first-party or regulator citation(s), 2 regulatory/action record(s), and 5 explicitly unresolved field(s). Review the cited evidence and current license status before making a decision.

Still have questions? Read the research library or email us at [email protected].